The NYSDOH AIDS Institute in partnership with various local health departments are sponsoring free Buprenorphine Waiver Eligibility Trainings for Clinical Providers. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for Opioid Use Disorder (OUD) is urgently needed. Physicians, Nurse Practitioners, Physician Assistants and Medical Residents are highly encouraged to attend.
Click here to register.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized 8-hour buprenorphine waiver training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the 8-hour buprenorphine waiver training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The 8-hour buprenorphine waiver training is offered in a ‘half and-half’ format [4.5 hours of in-person training followed by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Visit PCSS for more info including how to complete of all required training online: https://pcssnow.org/medication-assisted-treatment/
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with various providers.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
The Buprenorphine Waiver Training is supported in part by U90TP921994, Public Health Opioid Crisis, funded by the Centers for Disease Control and Prevention.
*For more information about waiver trainings held outside of NYC, email firstname.lastname@example.org
*For more information about waiver trainings held in NYC, email email@example.com